首页> 美国卫生研究院文献>Journal of Korean Medical Science >Warfarin-associated fetal intracranial hemorrhage: a case report.
【2h】

Warfarin-associated fetal intracranial hemorrhage: a case report.

机译:华法林相关的胎儿颅内出血:1例。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 27-yr-old woman who had been taking warfarin for 10 yr after mitral valve replacement became pregnant. After knowing her pregnancy, she received heparinization for nine weeks instead of warfarin, and took oral anticoagulant again. At 24 weeks of gestation, fetal ultrasound and MRI showed a left subdural hematoma, and the pregnancy was terminated. Subdural hematoma was demonstrated on autopsy. Fatal bleeding of the fetus is a rare complication of maternal warfarin medication, occurring mostly in the second or third trimester. There is no alternative regimen available, so that regular monitoring by fetal ultrasound and strict control of warfarin dose with regular measurement of prothrombin time are the best way to prevent intrauterine fetal death due to bleeding.
机译:一位二尖瓣置换术后服用华法林10年的27岁妇女怀孕。知道自己的怀孕后,她接受了肝素化治疗而不是使用华法林治疗了九周,并再次服用了口服抗凝药。妊娠24周时,胎儿超声和MRI显示左硬膜下血肿,并终止了妊娠。尸检证实了硬膜下血肿。胎儿致命性出血是母体华法林药物罕见的并发症,主要发生在妊娠中期或中期。没有其他可用的治疗方案,因此,定期进行胎儿超声监测和严格控制华法林剂量并定期测量凝血酶原时间是预防因出血而导致宫内胎儿死亡的最佳方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号